Cmpx stock forecast.
Wall Street Stock Market & Finance report, prediction for the future: You'll find the Compx International, Inc. - Class A share forecasts, stock quote and buy / sell signals below. According to present data Compx International, Inc. - Class A's CIX shares and potentially its market environment have been in a bullish cycle in the last 12 months ...
FORECASTS Analyst Sentiment LeaderboardIn this article, we answer “what is sales forecasting?” by breaking down its objectives, owners, methods, and best practices. Sales | What is REVIEWED BY: Jess Pingrey Jess served on the founding team of a successful B2B startup and has use...Compass Therapeutics, Inc. (CMPX) NasdaqCM - NasdaqCM Real Time Price. Currency in USD Follow 2W 10W 9M 1.6500 -0.0700 (-4.07%) At close: 04:00PM EST 1.6500 0.00 (0.00%) After hours: 04:20PM EST... The Compass Therapeutics stock forecast for tomorrow is $ 1.516608, which would represent a -1.52% loss compared to the current price. In the next week, the price of CMPX is expected to decrease by -2.77% and hit $ 1.497361. As far as the long-term Compass Therapeutics stock forecast is ...
Stock Price Forecast. The 6 analysts offering 12-month price forecasts for Compass Minerals International Inc have a median target of 43.50, with a high estimate of 82.00 and a low estimate of 36. ...Heading out for an outdoor adventure? Whether you’re planning a picnic, a hiking trip, or a beach day, one essential tool you need in your arsenal is a detailed weather 10 day forecast.According to . 1 Wall Street analyst that have issued a 1 year PSTV price target, the average PSTV price target is $8.00, with the highest PSTV stock price forecast at $8.00 and the lowest PSTV stock price forecast at $8.00.
Nowadays finding high-quality stock photos for personal or commercial use is very simple. You just need to search the photo using a few descriptive words and let Google do the rest of the work.Find real-time CIX - CompX International Inc stock quotes, company profile, news and forecasts from CNN Business.
66.07%. Get the latest Compass Therapeutics Inc. (CMPX) real-time quote, historical performance, charts, and other financial information to help you make more informed …The above table shows the analyst CMPX forecast and predictions for the stock price in 12 month’s time. Date Share Price Average 1Y Price Target Dispersion High Low 1Y Actual price Analysts; Current: US$1.77SFIX Stock 12 Months Forecast. $3.68. (5.75% Upside) Based on 10 Wall Street analysts offering 12 month price targets for Stitch Fix in the last 3 months. The average price target is $3.68 with a high forecast of $5.00 and a low forecast of $2.50. The average price target represents a 5.75% change from the last price of $3.48. Recent years have been quite the adventure for Block investors. Block stock increased over 11% in extended trading for the past quarter after the payments company posted earnings that exceeded Wall Street profit projections. Block is expected to be one of the most appealing and expensive stocks to buy in 2023.
Stock Price Forecast. The 6 analysts offering 12-month price forecasts for Compass Minerals International Inc have a median target of 43.50, with a high estimate of 82.00 and a low estimate of 36. ...
CMPX Overview Stock Screener Earnings Calendar Sectors Nasdaq | CMPX U.S.: Nasdaq Compass Therapeutics Inc. Watch NEW Set a price target alert After Hours Last Updated: Oct 13, 2023 4:38...
According to the issued ratings of 4 analysts in the last year, the consensus rating for Catalyst Pharmaceuticals stock is Buy based on the current 4 buy ratings for CPRX. The average twelve-month price prediction for Catalyst Pharmaceuticals is $24.75 with a high price target of $27.00 and a low price target of $24.00.Find the latest Catalyst Pharmaceuticals, Inc. (CPRX) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term ...Compass Therapeutics. Compass Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is developing proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. Its pipeline product candidates are CTX-471/ CD137 agonist and CTX-8371.Back to CMPX Overview. *The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. It is possible that this date will be updated in the future, once ... The Bridgebio Pharma Inc. stock price fell by -1.28% on the last day (Wednesday, 29th Nov 2023) from $28.84 to $28.47. During the last trading day the stock fluctuated 4.69% from a day low at $28.37 to a day high of $29.70. The price has been going up and down for this period, and there has been a -3.43% loss for the last 2 weeks.
Compass Therapeutics Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. ... The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction. ... CMPX Related stocks. Symbol 3M %Chg ; CMPX +4.67% : Compass Therapeutics ...66.07%. Get the latest Compass Therapeutics Inc. (CMPX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment ...CompX International Inc. (NYSE:CIX) posted its quarterly earnings data on Wednesday, November, 1st. The company reported $0.47 earnings per share for the quarter. The business earned $40.30 million during the quarter. CompX International had a net margin of 13.09% and a trailing twelve-month return on equity of 12.79%.Find the latest Immunovant, Inc. (IMVT) stock quote, history, news and other vital information to help you with your stock trading and investing.Stock Price Forecast. The 6 analysts offering 12-month price forecasts for Compass Minerals International Inc have a median target of 43.50, with a high estimate of 82.00 and a low estimate of 36. ...Here’s how equities historically perform in the week after Thanksgiving as markets shift to holiday season. Nov. 27, 2023 at 12:40 p.m. ET by Christine Idzelis. Stock market barrels into year ...
Latest CMPS News. View. COMPASS Pathways (CMPS, $5.98) entered Downtrend as Momentum indicator drops below 0 level on Nov 30, 2023. Tickeron - Stocks • 3 days ago. Compass Pathways to participate in upcoming Evercore investor conference. Globe Newswire • 10 days ago.
BOSTON, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the Company will participate in the following investor events during the month of September 2023. People use statistics daily for weather forecasts, predicting disease, preparing for emergencies, medical research, political campaigns, tracking sales, genetics, insurance, the stock market and quality testing.Find the latest Compass Therapeutics, Inc. CMPX analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports.Webull provides a variety of real-time CMPX stock news. You can receive the latest news about Compass Therapeutics Inc through multiple platforms. This information may help you make smarter investment decisions. About CMPX. Compass Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company. The Company is focused on …Get actionable alerts from top Wall Street Analysts. Find out before anyone else which stock is going to shoot up. Get powerful stock screeners & detailed portfolio analysis. Subscribe Now See Plans & Pricing. Get the latest Apexigen APGN Stock forecast and financial predictions, including earnings and sales forecast, on TipRanks.com.CompX International, Inc. engages in the manufacturer of security products used in the recreational transportation, postal, office and institutional furniture, cabinetry, tool stoCMPX Stock Forecast 2023. Compass Therapeutics boasts a robust drug pipeline, which explains why analysts are bullish on the stock. The Phase 2 and Phase 3 studies for cancer drug CTX-009 extend into H2 2023, at which time the company plans to initiate a Phase 1 study for its CTX-8371 drug also for cancer after filing an Investigational New Drug Application (IND) earlier in 2023.See the latest Compass Therapeutics Inc Ordinary Shares stock price (NASDAQ:CMPX), related news, valuation, dividends and more to help you make your investing decisions.GLTO Stock 12 Months Forecast. $5.67. (808.65% Upside) Based on 4 Wall Street analysts offering 12 month price targets for Galecto in the last 3 months. The average price target is $5.67 with a high forecast of $10.00 and a low forecast of $2.00. The average price target represents a 808.65% change from the last price of $0.62.
Compass Therapeutics, Inc. Common Stock (CMPX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.
The Compass Therapeutics, Inc. stock price gained 6.00% on the last trading day (Friday, 17th Nov 2023), rising from $1.50 to $1.59. During the last trading day the stock fluctuated 15.61% from a day low at $1.51 to a day high of $1.74. The price has fallen in 6 of the last 10 days and is down by -14.52% for this period.
Total Valuation. CMPX has a market cap or net worth of $224.33 million. The enterprise value is $55.37 million. Market Cap. 224.33M. Enterprise Value. 55.37M.Total Valuation. CMPX has a market cap or net worth of $224.33 million. The enterprise value is $55.37 million. Market Cap. 224.33M. Enterprise Value. 55.37M.LGVN Stock 12 Months Forecast. $8.00. (314.51% Upside) Based on 1 Wall Street analysts offering 12 month price targets for Longeveron in the last 3 months. The average price target is $8.00 with a high forecast of $8.00 and a low forecast of $8.00. The average price target represents a 314.51% change from the last price of $1.93.NSD:CMPX Detailed Stock Analysis, Stock Price Forecasts, Analyst Ratings, Financial Analysis, Stock News & Historic QuotesThe consensus price target of analysts on Wall Street is $9.17, which implies an increase of 78.95% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $8.00 and $11.00 respectively. As a result, CMPX is trading at a discount of -469.95% off the target high and -314.51% off the low.The Compass Therapeutics stock forecast for tomorrow is $ 1.516608, which would represent a -1.52% loss compared to the current price. In the next week, the price of CMPX is expected to decrease by -2.77% and hit $ 1.497361. As far as the long-term Compass Therapeutics stock forecast is ...Their COEP share price targets range from $3.00 to $6.00. On average, they expect the company's stock price to reach $4.33 in the next twelve months. This suggests a possible upside of 270.4% from the stock's current price. View analysts price targets for COEP or view top-rated stocks among Wall Street analysts.66.07%. Get the latest Compass Therapeutics Inc. (CMPX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment ...
Prev Close 2.81. 52 Week High 5.65. 52 Week High Date 12/23/22. 52 Week Low 1.30. 52 Week Low Date 05/04/22. Market Cap 380.788M. Shares Out 126.51M. 10 Day Average Volume 0.28M. Dividend -.Compass Therapeutics, Inc. Common Stock (CMPX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Total Valuation. CMPX has a market cap or net worth of $224.33 million. The enterprise value is $55.37 million. Market Cap. 224.33M. Enterprise Value. 55.37M.FCEL Stock 12 Months Forecast. Based on 6 Wall Street analysts offering 12 month price targets for Fuelcell Energy in the last 3 months. The average price target is $1.65 with a high forecast of $2.00 and a low forecast of $1.00. The average price target represents a 35.25% change from the last price of $1.22.Instagram:https://instagram. option servicegreat pot stocksbond broker near menasdaq peri It follows that stock’s current price would drop -591.82% in reaching the projected high whereas dropping to the targeted low would mean a loss of -403.14% for stock’s current value. Compass Therapeutics Inc (CMPX) estimates and forecastsThe CompX International stock forecast for tomorrow is $ 23.75, which would represent a -1.06% loss compared to the current price. In the next week, the price of CIX is expected to decrease by -9.90% and hit $ 21.62. As far as the long-term CompX International stock forecast is concerned, here ... where can i day trade with less than 25000mid cap stock index CMPX Stock 12 Months Forecast. $10.50. (510.47% Upside) Based on 2 Wall Street analysts offering 12 month price targets for Compass Therapeutics in the last 3 months. The average price target is $10.50 with a high forecast of $11.00 and a low forecast of $10.00. The average price target represents a 510.47% change from the last price of $1.72. dental insurance in georgia SFIX Stock 12 Months Forecast. $3.68. (5.75% Upside) Based on 10 Wall Street analysts offering 12 month price targets for Stitch Fix in the last 3 months. The average price target is $3.68 with a high forecast of $5.00 and a low forecast of $2.50. The average price target represents a 5.75% change from the last price of $3.48.Their COEP share price targets range from $3.00 to $6.00. On average, they expect the company's stock price to reach $4.33 in the next twelve months. This suggests a possible upside of 270.4% from the stock's current price. View analysts price targets for COEP or view top-rated stocks among Wall Street analysts.